Sign in

Anthony [for Joanne Wuensch]

Managing Director and Senior Equity Analyst at Citi

Joanne Wuensch is a Managing Director and Senior Equity Analyst at Citi, specializing in healthcare sector research, with focused coverage on companies such as Abbott Laboratories, Edwards Lifesciences, and Establishment Labs. She has delivered consistently strong performance, with approximately 60% of her recommendations proving profitable and an average return per transaction of 6.3%, earning her a 4.62-star rating on TipRanks and recognition as a top Wall Street analyst. Wuensch began her analyst career in the early 2000s, building a deep track record prior to joining Citi, where she has been a leading voice in medical devices and life sciences equity coverage. She is FINRA registered and holds relevant securities licenses, underscoring her professional credibility and compliance with industry standards.

Anthony [for Joanne Wuensch]'s questions to NVRO leadership

Anthony [for Joanne Wuensch]'s questions to NVRO leadership • Q2 2024

Question

Asked for strategies to counter increased competition beyond expanding the sales force and requested an update on the adoption and procedure volume from physicians trained on the Vyrsa SI joint system.

Answer

The company plans to counter competition by emphasizing its superior clinical data and using its new Vyrsa SI joint product as a 'door opener' in competitive accounts. Regarding Vyrsa, many trained physicians are still ramping up as they build their practices and get patients through the insurance approval process, but early adopters are starting to grow their volumes.

Ask Fintool Equity Research AI